App-Quantinova.ai

Validation of a Hospital-Acquired Venous Thrombosis Risk Assessment Model: The Medical Inpatient Thrombosis and Hemostasis (MITH) Study

N. Zakai - Society of Thrombosis and Hemostasis Research (GTH/ISTH) , 2022

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

N/A

Validation of the IMPROVE Hospital-Acquired Bleeding Risk Assessment Model in The Medical Inpatients Thrombosis and Hemostasis Study (MITH) Population

K. Wilkinson - Society of Thrombosis and Hemostasis Research (GTH/ISTH) , 2022

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

N/A

Validation of the IMPROVE Hospital-Acquired Venous Thrombosis Risk Assessment Model in The Medical Inpatients Thrombosis and Hemostasis Study (MITH) Population

A. Sparks - Society of Thrombosis and Hemostasis Research (GTH/ISTH) , 2022

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

N/A

Variability in thrombophilia testing in large international physician survey

M. Ellis - Society of Thrombosis and Hemostasis Research (GTH/ISTH) , 2022

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

N/A

Venous and Arterial Thromboembolism after Incident Colorectal Cancer in the Netherlands: Incidence, Predictors, and Prognosis

R. Anijs - Society of Thrombosis and Hemostasis Research (GTH/ISTH) , 2022

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

N/A

Venous thromboembolism and cancer. Incidence and sex difference.

K. Glise Sandblad - Society of Thrombosis and Hemostasis Research (GTH/ISTH) , 2022

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

N/A

Venous thromboembolism associated with oestrogen-containing contraceptives versus any hormonal risk factor: a comparison of recurrence rates

J. Knijp - Society of Thrombosis and Hemostasis Research (GTH/ISTH) , 2022

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

N/A

Venous thromboembolism in a large series of pediatric patients with acute lymphoblastic leukemia. Risk factors and use of prophylaxis.

R. Berrueco - Society of Thrombosis and Hemostasis Research (GTH/ISTH) , 2022

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

Heparin

Venous Thromboembolism in Bladder Cancer:Scope of the Problem and Patients’ Perspectives(VTE-BC)

O. Abdullah - Society of Thrombosis and Hemostasis Research (GTH/ISTH) , 2022

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

N/A

Venous thromboembolism in obese patients: a ten-year experience

B. Wee - Society of Thrombosis and Hemostasis Research (GTH/ISTH) , 2022

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

N/A

Venous Thromboembolism Prophylaxis Use by Pediatric Orthopedic Surgeons in Canada

J. Curwin - Society of Thrombosis and Hemostasis Research (GTH/ISTH) , 2022

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

N/A

Venous thromboembolism reoccurrence during factor Xa inhibitors in young patients associates with thoracic outlet syndrome and development of chronic thromboembolic pulmonary hypertension

M. Kaksonen - Society of Thrombosis and Hemostasis Research (GTH/ISTH) , 2022

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

N/A

Venous thrombosis associated with combined oral contraceptives: role of intrinsic thrombin generation potential

A. Rauch - Society of Thrombosis and Hemostasis Research (GTH/ISTH) , 2022

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

progestogen

VKORC1 -1639AA Genotype as a Possible Risk Factor for Venous Thromboembolism in Elderly Patients with FV Leiden Mutation

S. Kapustin - Society of Thrombosis and Hemostasis Research (GTH/ISTH) , 2022

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

N/A

Using Four-factor Prothrombin Complex Concentrate To Treat Coagulopathy In Liver Transplantation

Andrea Rivero - American Society of Anesthesiologists (ASA) , 2022

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Venous thrombosis

Prothrombin complex

title Case Association Between Extended Deep Vein Thrombosis Prophylaxis Following Hip Fracture Surgery And Postoperative 30-day Mortality Propensity Score-matched Observational Cohort Study

Young Ju Won - American Society of Anesthesiologists (ASA) , 2022

Therapeutic Area

Disease

Drug/Treatment

Blood/haematological Diseases

Venous thrombosis

Heparin

Management Of Edoxaban In Patients From The Global Emit-af/vte Program Undergoing Major Or Nonmajor Surgery

Christian Von Heymann - American Society of Anesthesiologists (ASA) , 2022

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Venous thrombosis

Edoxaban

Morbid Obesity And Coagulation Profiles Prior To Bariatric Surgery: A Bmi, Age And Gender Related Analysis

Davide Cattano - American Society of Anesthesiologists (ASA) , 2022

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Venous thrombosis

Monit

Erector Spinae Plane Block Decreases Narcotic Requirement In Patients Undergoing Subcutaneous Icd Placement Under Sedation

Jane Gui - American Society of Anesthesiologists (ASA) , 2022

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

Bupivacaine

FCN-289, a novel, potent and selective PI3Kδ inhibitor for the treatment of B-cell malignancies

Shu Lin - American Association for Cancer Research (AACR) , 2022

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Venous thrombosis

Idelalisib

Filters

7277 Abstracts